SK bioscience Co.,Ltd. (KRX:302440)
South Korea · Delayed Price · Currency is KRW
43,200
+550 (1.29%)
Mar 27, 2026, 3:30 PM KST
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2023 | FY 2022 | FY 2021 |
|---|
| Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
|---|
| 369.51B | 456.73B | 929.00B |
| -19.10% | -50.84% | - |
| 369.51B | 456.73B | 929.00B |
| -19.10% | -50.84% | - |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2023 | FY 2022 | FY 2021 |
|---|
| Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
|---|
| 158.22B | 224.16B | 695.86B |
| -29.42% | -67.79% | - |
| 185.96B | 217.83B | 48.41B |
| -14.63% | 349.99% | - |
| 21.20B | 13.78B | 184.50B |
| 53.88% | -92.53% | - |
| 3.89B | 651.33M | 233.27M |
| 497.76% | 179.22% | - |
| 231.61M | 305.04M | - |
| -24.07% | - | - |
| 369.51B | 456.73B | 929.00B |
| -19.10% | -50.84% | - |
Source: S&P Global Market Intelligence.